Holding(s) in Company

Dechra Pharmaceuticals PLC
14 November 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0009633180

Issuer Name

DECHRA PHARMACEUTICALS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Bank of America Corporation

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

4. Details of the shareholder

Name

City of registered office

Country of registered office

Merrill Lynch International

London

United Kingdom

5. Date on which the threshold was crossed or reached

10-Nov-2023

6. Date on which Issuer notified

13-Nov-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.725715

1.251822

5.977537

6807910

Position of previous notification (if applicable)

4.747418

1.277685

6.025103


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0009633180


5382191


4.725715

Sub Total 8.A

5382191

4.725715%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Right to Recall

n/a

n/a

9384

0.008239

Sub Total 8.B1


9384

0.008239%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Swaps

06/12/2023

N/A

Cash

68650

0.060277

Swaps

15/02/2024

N/A

Cash

17738

0.015574

Swaps

17/04/2024

N/A

Cash

310418

0.272556

Swaps

29/04/2024

N/A

Cash

248212

0.217937

Swaps

21/05/2024

N/A

Cash

16068

0.014108

Swaps

03/06/2024

N/A

Cash

391

0.000343

Swaps

08/07/2024

N/A

Cash

107865

0.094709

Swaps

31/07/2024

N/A

Cash

387974

0.340652

Swaps

12/08/2024

N/A

Cash

246

0.000216

Swaps

27/08/2024

N/A

Cash

120

0.000105

Swaps

16/09/2024

N/A

Cash

2

0.000002

Swaps

30/09/2024

N/A

Cash

105

0.000092

Swaps

07/10/2024

N/A

Cash

2886

0.002534

Swaps

31/10/2024

N/A

Cash

2491

0.002187

Swaps

08/11/2024

N/A

Cash

20000

0.017561

Swaps

11/11/2024

N/A

Cash

2

0.000002

Swaps

18/11/2024

N/A

Cash

11551

0.010142

Swaps

21/11/2024

N/A

Cash

218855

0.192161

Swaps

09/12/2024

N/A

Cash

348

0.000306

Swaps

06/05/2025

N/A

Cash

2413

0.002119

Sub Total 8.B2


1416335

1.243583%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Bank of America Corporation

Bank of America, National Association




Bank of America Corporation

Merrill Lynch International

4.498329


5.032198%

Bank of America Corporation

BofA Securities Europe SA




10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

13-Nov-2023

13. Place Of Completion

United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings